These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 1918882

  • 1. Formation of iso-ursodeoxycholic acid during administration of ursodeoxycholic acid in man.
    Beuers U, Fischer S, Spengler U, Paumgartner G.
    J Hepatol; 1991 Jul; 13(1):97-103. PubMed ID: 1918882
    [Abstract] [Full Text] [Related]

  • 2. Metabolism and effects on cholestasis of isoursodeoxycholic and ursodeoxycholic acids in bile duct ligated rats.
    Purucker E, Marschall HU, Winograd R, Matern S.
    Biochim Biophys Acta; 2001 Apr 03; 1526(1):44-52. PubMed ID: 11287121
    [Abstract] [Full Text] [Related]

  • 3. Isoursodeoxycholic acid: metabolism and therapeutic effects in primary biliary cirrhosis.
    Marschall HU, Broomé U, Einarsson C, Alvelius G, Thomas HG, Matern S.
    J Lipid Res; 2001 May 03; 42(5):735-42. PubMed ID: 11352980
    [Abstract] [Full Text] [Related]

  • 4. Study of human isoursodeoxycholic acid metabolism.
    Marschall HU, Roeb E, Yildiz Y, Busch N, Nguyen H, Purucker E, Thomas HG, Matern S.
    J Hepatol; 1997 Apr 03; 26(4):863-70. PubMed ID: 9126801
    [Abstract] [Full Text] [Related]

  • 5. Bile acid N-acetylglucosaminidation. In vivo and in vitro evidence for a selective conjugation reaction of 7 beta-hydroxylated bile acids in humans.
    Marschall HU, Matern H, Wietholtz H, Egestad B, Matern S, Sjövall J.
    J Clin Invest; 1992 Jun 03; 89(6):1981-7. PubMed ID: 1602004
    [Abstract] [Full Text] [Related]

  • 6. delta 22-Ursodeoxycholic acid, a unique metabolite of administered ursodeoxycholic acid in rats, indicating partial beta-oxidation as a major pathway for bile acid metabolism.
    Setchell KD, Yamashita H, Rodrigues CM, O'Connell NC, Kren BT, Steer CJ.
    Biochemistry; 1995 Apr 04; 34(13):4169-78. PubMed ID: 7703228
    [Abstract] [Full Text] [Related]

  • 7. Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitis.
    Rost D, Rudolph G, Kloeters-Plachky P, Stiehl A.
    Hepatology; 2004 Sep 04; 40(3):693-8. PubMed ID: 15349909
    [Abstract] [Full Text] [Related]

  • 8. Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health.
    Dilger K, Hohenester S, Winkler-Budenhofer U, Bastiaansen BA, Schaap FG, Rust C, Beuers U.
    J Hepatol; 2012 Jul 04; 57(1):133-40. PubMed ID: 22414767
    [Abstract] [Full Text] [Related]

  • 9. Single or multiple dose ursodeoxycholic acid for cholestatic liver disease: biliary enrichment and biochemical response.
    van de Meeberg PC, Wolfhagen FH, Van Berge-Henegouwen GP, Salemans JM, Tangerman A, van Buuren HR, van Hattum J, van Erpecum KJ.
    J Hepatol; 1996 Dec 04; 25(6):887-94. PubMed ID: 9007717
    [Abstract] [Full Text] [Related]

  • 10. Human liver class I alcohol dehydrogenase gammagamma isozyme: the sole cytosolic 3beta-hydroxysteroid dehydrogenase of iso bile acids.
    Marschall HU, Oppermann UC, Svensson S, Nordling E, Persson B, Höög JO, Jörnvall H.
    Hepatology; 2000 Apr 04; 31(4):990-6. PubMed ID: 10733557
    [Abstract] [Full Text] [Related]

  • 11. Increase of sulfated ursodeoxycholic acid in the serum and urine of patients with chronic liver disease after ursodeoxycholic acid therapy.
    Nakamura K, Yoneda M, Kimura A, Tamori K, Yokohama S, Sato Y, Kato T, Hasegawa T, Saito H, Aoshima M, Fujita M, Makino I.
    J Gastroenterol Hepatol; 1996 Apr 04; 11(4):385-90. PubMed ID: 8713707
    [Abstract] [Full Text] [Related]

  • 12. Prospective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosing cholangitis.
    Wunsch E, Trottier J, Milkiewicz M, Raszeja-Wyszomirska J, Hirschfield GM, Barbier O, Milkiewicz P.
    Hepatology; 2014 Sep 04; 60(3):931-40. PubMed ID: 24519384
    [Abstract] [Full Text] [Related]

  • 13. Effect of cholestyramine on bile acid pattern and synthesis during administration of ursodeoxycholic acid in man.
    Rust C, Sauter GH, Oswald M, Büttner J, Kullak-Ublick GA, Paumgartner G, Beuers U.
    Eur J Clin Invest; 2000 Feb 04; 30(2):135-9. PubMed ID: 10651838
    [Abstract] [Full Text] [Related]

  • 14. Intestinal absorption of the bile acid analogue 75Se-homocholic acid-taurine is increased in primary biliary cirrhosis, and reverts to normal during ursodeoxycholic acid administration.
    Lanzini A, De Tavonatti MG, Panarotto B, Scalia S, Mora A, Benini F, Baisini O, Lanzarotto F.
    Gut; 2003 Sep 04; 52(9):1371-5. PubMed ID: 12912872
    [Abstract] [Full Text] [Related]

  • 15. Defective canalicular transport and toxicity of dietary ursodeoxycholic acid in the abcb11-/- mouse: transport and gene expression studies.
    Wang R, Liu L, Sheps JA, Forrest D, Hofmann AF, Hagey LR, Ling V.
    Am J Physiol Gastrointest Liver Physiol; 2013 Aug 15; 305(4):G286-94. PubMed ID: 23764895
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression.
    Sinakos E, Marschall HU, Kowdley KV, Befeler A, Keach J, Lindor K.
    Hepatology; 2010 Jul 15; 52(1):197-203. PubMed ID: 20564380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.